Grastek: new sublingual tablet immunotherapy for grass allergyIntended for patients who have responded inadequately or are intolerant to conventional pharmacotherapy. Opsumit for long-term treatment of pulmonary arterial hypertensionNew oral endothelin receptor antagonist is effective alone or with a phosphodiesterase-5 inhibitor. Breo Ellipta: new combo inhaler for COPD Once-daily corticosteroid/LABA indicated for COPD maintenance and to reduce exacerbations. CPAP tackles hypertension Adempas for chronic thromboembolic pulmonary hypertension First drug approved to treat rare type of pulmonary hypertension. CLINICAL PEARLS: The wheezing infant: bronchiolitis? Asthma? Tudorza Genuair: new anticholinergic for COPD maintenance therapy Drug is a long-acting muscarinic receptor antagonist. Clinical Feature: Chronic obstructive pulmonary disease Management of stable COPD, with a focus on new developments and clinical controversies. Drug cuts morbidity in pulmonary arterial hypertension Clinical Notes: Limit azithromycin in pediatric respiratory infections A Canadian Paediatric Society statement discusses the use of azithromycin for upper and lower respiratory tract infections in otherwise healthy children. First Previous 48 49 50 51 52 Next Last
